Sign in
Not yet taking people in United StatesNo phase

Registry Tracking Breast Cancer, Heart and Diabetes Risk Screening in Women

Studies personalized screening and follow-up for breast cancer, heart and diabetes risk.

Key facts

Who runs it
Precision Health Equity Initiative
Where
Palo Alto, United StatesSee the site
Trial code
Registry title
The RISC Registry--Risk Informed Screening Registry
Status
Not yet recruiting
People taking part
10,000 people, planned
Started
1 Sept 2024
Expected to end
1 Sept 2035
Type of study
Observational
Treatments tested
  • Breast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up
Record updated
11 July 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18 or older who are unaffected by, or already diagnosed with, breast cancer, diabetes or heart disease, or who come in for related screening.

Age
18 to 100 years
Sex
Women only (sex assigned at birth)
Disease stage
Women with no breast cancer, diabetes or cardiovascular disease, or women already diagnosed with one of them, or women coming for cancer, metabolic health or heart screening.

Main reasons for not taking part

  • Not female (sex assigned at birth)
  • Under 18 years old
  • Not willing to sign the study consent form
  • Not willing to complete patient-reported surveys

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Female (Gender assigned at birth)
  • Unaffected women (by breast cancer, diabetes or cardiovascular disease)
  • Females who have been diagnosed with breast cancer, diabetes or cardiovascular disease
  • Females who are presenting for cancer, metabolic health or cardiovascular screening
  • Females presenting for mammography or other breast cancer screening procedures
  • Females presenting for cholesterol, other blood tests aimed at metabolic and cardiovascular health screening, ECG's, EKG's or other noninvasive scans for the presence of or risk of heart disease
  • Ages 18+
  • Willing to sign a study consent form
  • Willing to participate in PRO surveys
  • Willing to use technology to participate in the study procedures, if and as needed
  • Pregnant women may be included

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • PHEI--Precision Health Equity InitiativePalo Alto, United StatesContact: Mary Kay HardwickNot yet recruiting

About the trial

What the trial wants to find out

Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. Six in ten adults have one chronic disease; 4 in 10 have two or more. These are also leading drivers of the nation's $4.1 trillion in annual health care costs.

Read full original descriptionShow less

Cardiovascular disease is the number one cause of death for men and women, cancer is the second largest, with breast cancer being the second largest cause of death in women. Diabetes is the 8th highest cause of death for both men and women.

Routine screening, a focus on prevention, early detection, and patient engagement with proposed care plans, effective surveillance and follow up are some of the most effective ways to reduce the burden of chronic diseases across an individual's lifetime and at the population level.

Estimating dollar costs associated with non-compliance with screening and health management recommendations is complex and variable depending on the specific context, disease, and condition. But there is much evidence to indicate that a significant amount of these annual costs can be mitigated if compliance with health management recommendations increases, and health problems are prevented or detected early.

Access to screening and noncompliance with health management recommendations impact the entire population, but more disparities exist in racial and ethnic minorities and in the historically underserved for cancer, obesity, diabetes and cardiovascular disease.

The overall cost of these disparities in the U.S. has been estimated at around 1.24 trillion U.S. Dollars.

The RISC Registry seeks to pursue the intersection of breast cancer, metabolic, and cardiovascular risk in women and study the application of individualized multi-condition risk assessments, risk-informed or personalized screening, prevention and follow up care approaches in a broad cross section of patients. It pursues the hypothesis that these approaches accompanied by population appropriate methods of clinician and patient engagement may increase understanding and compliance with breast cancer, obesity, and metabolic/cardiovascular/cardiometabolic risk screening, surveillance and follow up recommendations by empowering women to make healthier choices.

In doing so, these methods may identify ways to address disparities in screening and patient care and ultimately promote early detection or even reversal of adverse health conditions, improve overall personal health, and reduce overall health care costs.

The primary focus is cancer, cardiovascular and metabolic health screening with a focus on utilization of Precision Screening. (Precision Screening attempts to separate those who will benefit from screening from those that may not, through use of information on disease risk.)

The study will start by focusing on women and risk for these diseases and health conditions.

Treatments tested

  • Breast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Risk Informed Screening Registry (The RISC Registry)
Plain-language title
Registry Tracking Breast Cancer, Heart and Diabetes Risk Screening in WomenGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05848856, who can take part
Record updated
11 July 2024